Obesema 1mg Injection
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
Obesema 1mg Injection
contains Semaglutide 1mg per weekly dose in a pre-filled pen, manufactured by Abbott. This is the maximum approved dose in the Obesema diabetes range, delivering superior HbA1c reduction (~1.8%) and greater weight loss than lower doses. It is equivalent to Ozempic 1mg at a fraction of the branded cost, making it the preferred long-term option for patients requiring maximum GLP-1 efficacy.
Benefits:
- Superior HbA1c reduction (~1.8%) and ~5% body weight loss versus the 0.5mg dose
- 26% reduction in MACE risk demonstrated in the SUSTAIN-6 cardiovascular outcomes trial
- Once-weekly injection for sustained adherence and maximum convenience
- Maximum approved dose in the Obesema injectable diabetes range
- Manufactured by Abbott with globally certified quality standards
How It Works:
At 1mg, semaglutide achieves near-maximal GLP-1 receptor engagement within the approved diabetes dose range. Central appetite suppression is robust, gastric emptying is significantly delayed, and pancreatic insulin secretion is powerfully stimulated in a glucose-dependent manner. Blood glucose and body weight fall progressively over months with additional cardiovascular, blood pressure, and lipid benefits.
Dosage and Administration:
Inject 1mg subcutaneously once weekly after at least 4 weeks on the 0.5mg dose, or as a prescribed maintenance dose. Administer into the abdomen, thigh, or outer upper arm. Rotate injection sites each week. This is the maximum dose in the Obesema injectable diabetes range.
Side Effects:
Common: nausea, diarrhoea, vomiting, constipation, decreased appetite, abdominal pain. Uncommon: fatigue, dizziness, elevated resting heart rate. Serious: pancreatitis, gallbladder disease, diabetic retinopathy worsening.
Precautions:
Contraindicated in personal or family history of medullary thyroid carcinoma or MEN2. Monitor patients with diabetic retinopathy during rapid HbA1c improvement. Adjust concurrent insulin and sulphonylurea doses as needed.
Obesema Dosage Comparison Guide
| Strength | Best For | Onset | Duration | Link |
|---|---|---|---|---|
| 0.25mg | Lower strength option | 2–4 wks | Weekly | View → |
| 0.5mg | Standard strength option | 2–4 wks | Weekly | View → |
| 1mg | Popular strength option | 2–4 wks | Weekly | Current |
| 1.7mg | Higher strength option | 2–4 wks | Weekly | View → |
| 2.4mg | Maximum strength variant | 2–4 wks | Weekly | View → |
* Always consult your doctor before changing your dosage. This information is for educational reference only.
Frequently Asked Questions
Q1: What is Obesema 1mg used for?
Obesema 1mg is the maximum dose in the Obesema injectable diabetes range by Abbott, prescribed for adults with type 2 diabetes requiring optimal glycaemic control and superior weight reduction after completing the titration phase.
Q2: How does Obesema 1mg compare to Ozempic 1mg?
Obesema 1mg contains the same semaglutide active ingredient at the same dose as Ozempic 1mg. As an equivalent product by Abbott, it delivers the same clinical outcomes — HbA1c reduction, weight loss, and cardiovascular benefit — at substantially lower cost.
Q3: Can Obesema 1mg be used for weight loss without diabetes?
While the 1mg dose is approved for type 2 diabetes, some prescribers use it off-label for weight management. The higher 1.7mg and 2.4mg doses in the Obesema range are specifically designed for weight management.
Q4: What cardiovascular benefits does Obesema 1mg offer?
The SUSTAIN-6 trial demonstrated that semaglutide 1mg reduced major adverse cardiovascular events by 26% in patients with established cardiovascular disease, making it a preferred agent in this high-risk population.
Q5: How long until I see results with Obesema 1mg?
Most patients notice appetite reduction within the first 2–4 weeks. Significant HbA1c improvement typically occurs within 8–12 weeks. Body weight reduction continues progressively over 6–12 months of treatment.
Customer Reviews
Metro Hospital Pharmacy
UK · 2 weeks ago
“Reliable supplier. Product met all our quality standards. Great communication throughout the entire procurement process.”
Global Meds Supply
Germany · 6 weeks ago
“Ordering from Medionix for several months now. Consistent pharmaceutical quality and professional service every time.”
Thomas B.
Australia · 4 months ago
“Legitimate pharmaceutical supplier. Packaging intact, expiry dates clearly printed, batch numbers traceable. Very satisfied.”
Robert Chen
Canada · 1 month ago
“Very satisfied with the order. Packaging was secure and delivery was on time. Quality matches the description perfectly.”
Dr. Emily Parker
UK · 2 months ago
“Impressed with the professionalism. Certificate of Analysis provided on request. Will be placing repeat orders for our clinic.”
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.